Poultry Bacterial Disease Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1791387
리서치사:Lucintel
발행일:2025년 08월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 가금류 세균병 백신 시장 전망은 NDV, 말렉병, IBD, 감염성 기관지염 및 독감 시장의 기회에 의해 유망시되고 있습니다. 세계의 가금류 세균병 백신 시장은 2025-2031년 연평균 복합 성장률(CAGR) 7.5%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 가금류 제품 수요 증가, 동물 건강에 대한 의식 증가 및 규제 요구 사항입니다.
Lucintel사의 예측에 의하면, 유형별로는 가금류의 질병 예방에 널리 받아들여지고 있기 때문에 살처분이 예측 기간중 최대의 부문인 것을 계속합니다.
용도별로 감염성 기관지염은 높은 유행률과 가금류의 건강에 미치는 영향으로 최대 부문을 유지하는 것으로 보입니다.
지역별로는 아시아태평양은 가금류 생산량이 많기 때문에 예측 기간 동안 가장 높은 성장이 예상됩니다.
150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.
가금류 세균병 백신 시장의 새로운 동향
가금류의 건강 및 항생제 사용에 대한 의존에 대한 관심이 높아지고 있는 가운데, 세계의 가금류 세균병 백신 시장은 다양한 새로운 동향에 의해 변화하고 있습니다. 백신 기술의 혁신이 진행되고 식품의 안전성에 대한 관심도 높아지고 있습니다. 가금류 세균병 시장의 추가 변화로 인해 주목되는 동향은 다음과 같습니다.
AMR 예방 : 항균제 내성의 문제는 가금류 산업을 기로에 세우고, 이 분야는 백신이라는 보다 전략적인 대안을 제공하도록 변화하고 있습니다. 백신은 항생제를 사용하지 않고 조류를 박테리아 감염으로부터 보호하고 AMR을 감소시킵니다. 제조업체는 살모넬라 및 대장균과 같은 일반적인 가금류 질병을 표적으로 하는 백신의 제조에 동향하고 있습니다. 이러한 백신은 박테리아 감염을 억제하는 데 도움이 되지만 내성을 조장하지는 않습니다. 정부와 소비자가 깨끗하고 안전한 육류 제품을 찾는 동안이 동향은 중요합니다.
재조합 백신 및 DNA 기반 백신 : 닭고기 산업에서는 재조합 백신 및 DNA 기반 백신의 사용이 증가하고 있습니다. 이러한 백신은 개발된 박테리아의 유형에 특이적이며 효율적으로 작용합니다. 일반적으로 부작용도 적습니다. 살아있는 병원체가 존재하지 않더라도 양호한 면역 반응을 일으킬 수 있으므로 가금류와 소비자에 대한 안전성이 향상됩니다. 게다가 DNA 백신은 제조와 규모 확대가 용이하기 때문에 대규모 가금류 사업, 특히 신흥국 시장에서는 비교적 저렴하게 도입할 수 있습니다.
커스터마이징 가능한 다계통 백신 : 여러 세균성 병원체에 대한 광범위한 방어를 위한 효과적인 도구가 되는 커스터마이즈 가능한 다계통 백신의 개발이 보급되고 있습니다. 다 계통 백신은 한 번의 예방 접종으로 다양한 박테리아 질병에 대한 가금류의 면역력을 제공하기 위해 오늘날보다 요구되고 있습니다. 이것은 백신 접종의 필요성을 줄이고 가금류 농장의 백신 접종을 효율화합니다.
백신 전달 시스템의 혁신 : 백신 전달 시스템의 혁신은 가금류 백신 시장에서 가장 중요한 동향이 되고 있습니다. 종래의 주사법 대신에, 경구 백신이나 물 기반의 전달 시스템 등, 보다 효율적이고 스트레스가 적은 방법이 검토되고 있습니다. 이를 통해 취급 시간 단축, 조류 스트레스 완화, 전반적인 복지 개선 및 더 나은 백신 섭취가 가능합니다. 백신 전달의 혁신은 또한 더 나은 커버리지와 더 정확한 투여를 보장하며, 특히 대규모 가금류에서 백신 접종 캠페인의 전반적인 성공으로 이어집니다.
정부 지원 및 규제 강화 : 세계 정부는 가금류 건강 및 백신 사용 규제에 보다 적극적인 역할을 하고 있습니다. 식품의 안전성과 질병 예방에 대한 우려가 높아짐에 따라, 대부분의 국가에서 특히 세균성 질병에 관한 가금류의 백신 접종에 대한 규제가 강화되고 있습니다. 이러한 규제 강화의 움직임은 국가의 질병 대책 프로그램의 일환으로서 백신 수요를 강제하는 것입니다. 게다가 각국 정부는 백신 기술의 연구개발을 점점 지원하고 있으며, 이로 인해 제조업체는 엄격한 안전성 및 유효성 기준을 충족하는 새로운 백신 제형에 투자하게 되었습니다.
항균제 내성 예방에 주력, 재조합 백신, 다계통 백신 제제, 백신 전달의 혁신, 정부 지원 강화 등 가금류 세균병 백신 시장의 새로운 동향은 업계를 크게 재구축하고 있습니다. 이러한 추세는 가금류의 건강 상태를 개선하고 질병 대책에 대한 노력을 강화하며 항생제를 사용하지 않는 보다 안전한 가금류 생산에 기여합니다.
가금류 세균병 백신 시장의 최근 동향
가금류 세균병 백신 시장은 제조업체 및 연구자가 가금류의 세균 감염이라는 과제를 다루는 중에서 큰 발전을 이루고 있습니다. 최근의 동향은 백신의 효능 향상, 이용가능성 확대, 항생제 의존도 감소에 중점을 두고 있습니다. 다음 개발은 가금류의 건강 요구를 충족시키기 위해 업계가 어떻게 진화하고 있는지를 돋보이게 합니다.
재조합 백신 기술의 진보 : 재조합 백신은 가금류 세균병 백신의 역학을 변화시키고 있습니다. 재조합 백신 생산의 유전 공학은 살아있는 병원체를 이용하는 전통적인 길을 걷지 않고 특정 균주에서 사용하기위한보다 안전하고 효과적인 제품을 개발합니다. 그 특이성의 높이와 부작용의 저감이, 이러한 재조합 백신의 보급에 공헌해, 살모넬라균 및 대장균, 마이코플라스마 감염증으로부터 조류를 지키는 면역 대책으로서 서서히 보급되고 있습니다.
신흥 시장에서의 백신 개척 : 신시장에서는 합리적인 가격으로 입수하기 쉬운 가금용 백신 수요가 높아지고 있습니다. 제조업체 각 회사는 이러한 백신을 더 큰 시장에서도 사용할 수 있도록 함으로써 이러한 수요를 충족합니다. 상대적으로 저렴한 비용으로 대규모 가금류 농장에 이상적인 새로운 백신 제제가 출현하고 있습니다. 이러한 확대는 가금류 생산량이 많지만 수의학에 대한 접근이 제한된 지역의 세균병을 조절하는 데 필수적입니다. 또한 음식의 안전과 가금류의 건강을 보장하기 위한 세계의 노력에도 도움이 됩니다.
백신 전달 시스템 개선 : 백신 전달 시스템의 새로운 기술 혁신은 백신 접종의 효율을 향상시키고 가금류에 대한 스트레스를 완화하는 데 도움이 됩니다. 경구 백신과 수성 백신은 투여가 용이하고 처리 시간을 단축할 수 있는 방법으로 현재 개발 중입니다. 이러한 시스템은 대규모 가금류 분야에서 인건비를 절감하고 보다 균일한 백신 분포를 확보할 수 있기 때문에 유리합니다. 향상된 공급 시스템의 채택으로 백신 접종률이 향상되고 질병 예방과 가금 전체의 건강 상태가 개선되었습니다.
정부와 민간 부문의 협업 : 가금류 세균병 백신의 처방 및 배포 분야에서는 정부와 기타 민간 부문과의 협력이 중요해지고 있습니다. 관민 파트너십은 백신 제조 가속화와 국내 보편적 백신 접종 프로그램의 제도화를 촉진하고 있습니다. 정부는 연구개발을 지원하고 규제 승인을 제공하며 미미한 수준에서 농부에게 공급하는 반면 민간 부문은 기술적으로 진행된 지역과 제조 시설을 제공합니다. 이 통합은 여러 지역에서 백신을 얻고 시행하는 데 도움이 됩니다.
항생제를 사용하지 않는 가금류 사육으로의 전환 : 소비자의 의식과 수요로 인해 국제사회는 보다 안전하고 건강한 항생제를 사용하지 않는 닭고기 제품의 생산에 주력할 수밖에 없습니다. 이러한 배경에서 가금류 산업은 항생제를 사용하는 것이 아니라 백신 기반 질병 대책에 중점을 두고 있습니다. 제조업체 각 회사는 광범위한 박테리아 방어를 제공할뿐만 아니라 항생제를 사용하지 않는 백신의 제조에 주력하고 있습니다. 이 개발은 항생제 내성과 관련된 우려를 해결하고 장기적인 가금류의 지속가능성을 보장하는 데 매우 중요합니다.
재조합 기술의 진보, 백신 선택의 확대, 전달 시스템의 개선, 관민의 협력, 항생제 미사용 가금류에 대한 주력 등 가금류 세균병 백신 시장의 최근 동향은 업계를 재구성하고 있습니다. 이러한 혁신은 가금류의 건강을 개선하고 항생제에 대한 의존도를 줄이고 세계에서 더 안전하고 지속 가능한 가금류 생산을 보장합니다.
목차
제1장 주요 요약
제2장 시장 개요
배경 및 분류
공급망
제3장 시장 동향 및 예측 분석
거시경제 동향 및 예측
업계의 촉진요인 및 과제
PESTLE 분석
특허 분석
규제 환경
제4장 세계의 가금류 세균병 백신 시장 : 유형별
개요
유형별 매력 분석
생 : 동향 및 예측(2019-2031년)
약독 : 동향 및 예측(2019-2031년)
불활화 : 동향 및 예측(2019-2031년)
제5장 세계의 가금류 세균병 백신 시장 : 용도별
개요
용도별 매력 분석
NDV : 동향 및 예측(2019-2031)
마렉병 : 동향 및 예측(2019-2031년)
IBD : 동향 및 예측(2019-2031)
감염성 기관지염 : 동향 및 예측(2019-2031년)
인플루엔자 : 동향 및 예측(2019-2031)
기타 : 동향 및 예측(2019-2031)
제6장 지역 분석
개요
세계의 가금류 세균병 백신 시장 : 지역별
제7장 북미의 가금류 세균병 백신 시장
개요
북미의 가금류 세균병 백신 시장 : 유형별
북미의 가금류 세균병 백신 시장 : 용도별
미국의 가금류 세균병 백신 시장
멕시코의 가금류 세균병 백신 시장
캐나다의 가금류 세균병 백신 시장
제8장 유럽의 가금류 세균병 백신 시장
개요
유럽의 가금류 세균병 백신 시장 : 유형별
유럽의 가금류 세균병 백신 시장 : 용도별
독일의 가금류 세균병 백신 시장
프랑스의 가금류 세균병 백신 시장
스페인의 가금류 세균병 백신 시장
이탈리아의 가금류 세균병 백신 시장
영국의 가금류 세균병 백신 시장
제9장 아시아태평양의 가금류 세균병 백신 시장
개요
아시아태평양의 가금류 세균병 백신 시장 : 유형별
아시아태평양의 가금류 세균병 백신 시장 : 용도별
일본의 가금류 세균병 백신 시장
인도의 가금류 세균병 백신 시장
중국의 가금류 세균병 백신 시장
한국의 가금류 세균병 백신 시장
인도네시아의 가금류 세균병 백신 시장
제10장 세계 기타 지역의 가금류 세균병 백신 시장
개요
세계 기타 지역의 가금류 세균병 백신 시장 : 유형별
세계 기타 지역의 가금류 세균병 백신 시장 : 용도별
중동의 가금류 세균병 백신 시장
남미의 가금류 세균병 백신 시장
아프리카의 가금류 세균병 백신 시장
제11장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter's Five Forces 분석
경쟁 기업간 경쟁 관계
구매자의 협상력
공급기업의 협상력
대체품의 위협
신규 참가업체의 위협
시장 점유율 분석
제12장 기회 및 전략 분석
밸류체인 분석
성장 기회 분석
유형별 성장 기회
용도별 성장 기회
세계 가금류 세균병 백신 시장의 새로운 동향
전략 분석
신제품 개발
인증 및 라이선싱
합병, 인수, 계약, 제휴 및 합작 사업
제13장 밸류체인에서 주요 기업의 기업 프로파일
경쟁 분석
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova(R)
Elanco
Qyh Biotech Co.
Hester Biosciences
Pulike
Phibro Animal Health Corporation
제14장 부록
AJY
영문 목차
영문목차
The future of the global poultry bacterial disease vaccine market looks promising with opportunities in the NDV, Marek's disease, IBD, infectious bronchitis, and influenza markets. The global poultry bacterial disease vaccine market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising demand for poultry products, the growing awareness of animal health, and regulatory requirements.
Lucintel forecasts that, within the type category, killed will remain the largest segment over the forecast period due to its widespread acceptance for poultry disease prevention.
Within the application category, infectious bronchitis will remain the largest segment due to its high prevalence and impact on poultry health.
In terms of region, APAC is expected to witness the highest growth over the forecast period due to high poultry production.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Poultry Bacterial Disease Vaccine Market
With rising attention on poultry health and its dependency on the use of antibiotics, the worldwide poultry bacterial disease vaccine market is changing with various emerging trends. There are innovations going on in terms of vaccine technology and growing concern for food safety as well. Trends that are in focus for further modification of the poultry bacterial disease market are as follows:
Prevention of AMR: The issue of antimicrobial resistance places the poultry industry at a crossroads, and the sector has been changing to provide a more strategic alternative: vaccines. Vaccines protect birds from bacterial infections without antibiotics, reducing AMR. Manufacturers have trended toward the production of vaccines that target common poultry diseases such as Salmonella and E. coli. Such a vaccine helps keep bacterial infection at bay but does not encourage resistance. This trend is significant as governments and consumers call for clean and safe meat products.
Recombinant and DNA-Based Vaccines: The use of recombinant and DNA-based vaccines is on the rise in the poultry industry. Such vaccines are specific and work efficiently with respect to the bacterial type for which they have been developed. They generally have minimal side effects. Their safety to poultry and consumers is enhanced because they are able to elicit a good immune response, but in the absence of live pathogens. Furthermore, DNA vaccines are easier to produce and scale, hence are relatively cheaper for large-scale poultry farming operations, especially in developing markets.
Customizable and Multi-Strain Vaccines: The development of customizable and multi-strain vaccines that would be an effective tool for broad protection against several bacterial pathogens is increasing in prevalence. Multi-strain vaccines are more sought after today since they provide poultry immunity to a variety of bacterial diseases by taking one vaccine dose. This cuts the need for vaccination and streamlines the vaccination of poultry farms.
Innovation in Vaccine Delivery Systems: Vaccine delivery systems innovation is becoming the most significant trend in the poultry vaccine market. Replacing the traditional injection methods, more efficient and less stressful methods, such as oral vaccines and water-based delivery systems, are being considered. These have a reduced time of handling, stress to the birds, and overall welfare improvement, and better vaccine uptake. Vaccine delivery innovations also ensure there is better coverage and more accurate dosing, leading to the overall success of campaigns for vaccination, especially in poultry farming on large scales.
Increased Government Support and Regulation: Governments around the world are playing a more active role in regulating poultry health and vaccine use. As concerns over food safety and disease prevention grow, most countries will have stronger regulations for vaccination in their poultry, especially regarding bacterial diseases. This regulatory push is forcing the demand for vaccines as part of national disease control programs. Moreover, governments are increasingly supporting research and development in vaccine technology, which is making manufacturers invest in new vaccine formulations that meet strict safety and efficacy standards.
The emerging trends in the poultry bacterial disease vaccine market, including the focus on antimicrobial resistance prevention, recombinant vaccines, multi-strain formulations, vaccine delivery innovations, and increased government support, are significantly reshaping the industry. These trends are improving poultry health, enhancing disease control efforts, and contributing to safer, antibiotic-free poultry production.
Recent Developments in the Poultry Bacterial Disease Vaccine Market
The poultry bacterial disease vaccine market is undergoing significant development as manufacturers and researchers work to address the challenges of bacterial infections in poultry. Recent developments are focused on improving vaccine efficacy, expanding accessibility, and reducing reliance on antibiotics. The following developments highlight how the industry is evolving to meet the needs of poultry health.
Advances in Recombinant Vaccine Technology: Recombinant vaccines are changing the dynamics of poultry bacterial disease vaccines. Genetic engineering in producing recombinant vaccines develops a safer, more effective product for use by specific strains without having to go through the traditional path of utilizing live pathogens. Their specificity level and reduced side effects contribute to the gain of these recombinant vaccines, making them progressively popular for immunity protection of birds from Salmonella and E. coli, and Mycoplasma infections, thus improving poultry health as well as reducing the need for antibiotics.
Vaccine Development in New Markets: There is an increased demand for affordable and accessible poultry vaccines in new markets. Manufacturers are fulfilling this demand by making these vaccines accessible to larger markets. New vaccine formulations are emerging that are of relatively low cost and ideal for large poultry farms. This expansion is vital for controlling bacterial diseases in regions with high poultry production but limited access to veterinary care. It also helps in global efforts to ensure food safety and poultry health.
Improved Vaccine Delivery Systems: New innovations in vaccine delivery systems are helping to improve the efficiency of vaccination, thus reducing the stress on poultry. Oral vaccines and water-based vaccines are methods that are currently being developed for easy administration, thereby reducing handling time. The systems are advantageous for large poultry farms, as they decrease labor costs and ensure more uniform distribution of the vaccine. Vaccination coverage has increased due to the adoption of improved delivery systems, resulting in better disease prevention and overall poultry health.
Collaborations Between Government and Private Sector: Collaboration between governments and other private sector units is becoming important in the area of poultry bacterial disease vaccine formulation and distribution. Public-Private Partnerships are facilitating acceleration in vaccine production and the institutionalization of universal vaccination programs in the country. Governments are supporting R&D, providing regulatory clearances, and supplies to farmers at the grassroots level, whereas the private sector is bringing technologically advanced areas and manufacturing facilities. This integration is helping with vaccine availability and implementation across many regions.
Shift toward Raising Antibiotic-Free Poultry: Consumer awareness and demand are forcing the international community to concentrate on producing safer and healthier antibiotic-free poultry products. This aspect is encouraging the poultry industry to focus on vaccine-based disease control instead of antibiotic use. There has been a focus from manufacturers on making vaccines that not only offer broad-spectrum bacterial protection but do not involve antibiotic drugs. This development is crucial in addressing the concerns associated with antibiotic resistance and ensuring the sustainability of poultry farming in the long term.
Recent developments in the poultry bacterial disease vaccine market, such as advancements in recombinant technology, expanded vaccine options, improved delivery systems, public-private collaborations, and a focus on antibiotic-free poultry production, are reshaping the industry. These innovations are improving poultry health, reducing reliance on antibiotics, and ensuring safer, more sustainable poultry production worldwide.
Strategic Growth Opportunities in the Poultry Bacterial Disease Vaccine Market
The global poultry bacterial disease vaccine market is expected to grow with increased poultry production and heightened awareness about disease prevention. Strategic growth opportunities exist across a number of key applications, such as joint efforts in improving poultry health, increasing vaccine access, and reducing the impact of bacterial diseases. The following sections identify five key growth opportunities in the market.
Development of Tailored Vaccines for Emerging Markets: One major growth area is in the case of emerging markets, such as poultry bacterial disease vaccines. Regions with difficulties and limited veterinary services in regard to disease control constitute a critical gap that can be exploited through designing cost-effective, region-specific vaccines for the specific needs of poultry farms. Manufacturers would improve poultry health by making the vaccine more accessible at a low price in production-intensive, but resource-poor, regions.
Expansion of Vaccine Delivery Innovations: Innovations in vaccine delivery systems, such as oral vaccines and water-based delivery methods, represent a major growth opportunity. These systems offer a less invasive and more efficient way to vaccinate large flocks, reducing stress on poultry and improving vaccine uptake. Expanding the use of these delivery methods, particularly in large-scale poultry operations, will improve vaccination coverage and lead to better disease prevention and poultry health management.
Inter-government, inter-institutional, and public-private collaborations in research and development will provide significant growth opportunities in the poultry vaccine market. Inter-government, inter-institutional, and public-private collaboration in research and development will facilitate accelerating the development of new vaccine formulations, development of more effective vaccines, and expansion of the coverage of vaccination programs. With joint resources and expertise, stakeholders can leverage their differences and challenge barriers toward developing safe and efficacious vaccines for poultry worldwide.
Focus on Sustainable and Antibiotic-Free Poultry Production: With the rising demand for antibiotic-free poultry, manufacturers will find a good opportunity to develop vaccines that prevent bacterial diseases without antibiotics. Consumers' growing desire for safer and more sustainable meat products will lead to further demand for vaccines as an alternative to antibiotics. Therefore, this trend toward antibiotic-free production methods will drive growth in the poultry bacterial disease vaccine market.
Increase Support towards Poultry Health Programs: Growth opportunities for vaccine manufacturers to improve poultry health arise from initiatives undertaken by governments. Stricter regulations and guidelines for countries in terms of poultry disease prevention are creating immense pressure to put effective vaccination programs in place, thus creating further opportunities for manufacturers by being aligned to national health initiatives and providing vaccines that are of regulatory requirement quality. By contributing to these public health programs, vaccine manufacturers can expand market presence and achieve better disease control worldwide.
Strategic growth opportunities in the poultry bacterial disease vaccine market are centered around developing tailored vaccines for emerging markets, expanding vaccine delivery innovations, fostering research collaborations, focusing on antibiotic-free production, and supporting government health initiatives. These opportunities will drive market expansion while improving poultry health and ensuring safer, more sustainable poultry production.
Poultry Bacterial Disease Vaccine Market Driver and Challenges
The global poultry bacterial disease vaccine market is driven by several technological, economic, and regulatory drivers and challenges. These factors determine the development, production, and distribution of vaccines intended to improve poultry health and reduce bacterial infections. Understanding these drivers and challenges will help in the navigation of the market dynamics.
The factors responsible for driving the poultry bacterial disease vaccine market include:
1. Technological Advancements in Vaccine Development: Advances in vaccine development technology, for instance, recombinant DNA and developed vaccine delivery systems, are key factors of this market. Such advancements provide more effective vaccines and the immunity that results from them, especially against certain strains of bacteria, help poultry be better managed for health and productivity.
2. Increased demand for antibiotic-free poultry: Increasing consumer preference for antibiotic-free poultry is driving demand for vaccines as an alternative to antibiotics in disease prevention. Vaccines help protect poultry from bacterial infections without contributing to antimicrobial resistance, aligning with consumer expectations for safer, healthier meat products. This shift is encouraging the adoption of vaccines in the poultry industry.
3. Government Regulations and Health Initiatives: Demand for poultry bacterial disease vaccines is mainly driven by more stringent government regulations in the area of poultry health and disease prevention. Most governments have adopted vaccination programs and higher standards for poultry disease control, thereby increasing the usage of vaccines in poultry farms worldwide.
4. Increase in Poultry Production: In such a scenario of increasing global poultry production, disease prevention measures must become more effective. The growing demand for poultry products is pushing for the use of vaccines as a means to control bacterial diseases and reduce mortality with an improvement in overall flock health.
5. Food Safety and Public Health Awareness are on the Rise: Heightened awareness of food safety and public health concerns is increasing the demand for vaccines in poultry farming. Consumers are more aware of the potential risks associated with bacterial infections in poultry, which has led to a greater emphasis on preventive measures, including vaccination.
Challenges in the poultry bacterial disease vaccine market are:
1. High Cost of Vaccine Development: The main barrier in the poultry bacterial disease vaccine market is the high cost of developing a new vaccine. Research and development require a lot of time, resources, and expertise. This usually proves to be a challenge for smaller companies to venture into the market and provide vaccines for farmers in developing countries.
2. Issues Surrounding Vaccine Distribution and Storage: Efficient distribution and storage of vaccines, especially in regions with limited infrastructure, remain a challenge. Vaccines often require specific storage conditions, such as refrigeration, which can complicate their distribution in rural areas or developing countries. Overcoming these logistical hurdles is essential for ensuring broad vaccine access.
3. Limited Vaccine Efficacy for Some Strains: Another challenge is the limited efficacy of vaccines for certain bacterial strains. While vaccines for some diseases, such as Salmonella, are widely available, there are still gaps in vaccine development for less common bacterial pathogens. Further research is needed to develop vaccines that offer broad protection against a wider range of bacteria.
Drivers for the global poultry bacterial disease vaccine include recent advances in technology, increasing consumer demand for antibiotic-free poultry, government regulations, and growth in poultry production. There is also awareness of food safety. The market growth would be a hurdle against some of the challenges including the high cost of vaccine development, issues of distribution and storage, as well as the limited efficacy for certain strains. These challenges would have to be addressed in order to extend and increase the poultry vaccines' global reach and impact.
List of Poultry Bacterial Disease Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, poultry bacterial disease vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry bacterial disease vaccine companies profiled in this report include:
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova(R)
Elanco
Qyh Biotech Co.
Hester Biosciences
Pulike
Phibro Animal Health Corporation
Poultry Bacterial Disease Vaccine Market by Segment
The study includes a forecast for the global poultry bacterial disease vaccine market by type, application, and region.
Poultry Bacterial Disease Vaccine Market by Type [Value from 2019 to 2031]:
Live
Attenuated
Killed
Poultry Bacterial Disease Vaccine Market by Application [Value from 2019 to 2031]:
NDV
Marek's Disease
IBD
Infectious Bronchitis
Influenza
Others
Poultry Bacterial Disease Vaccine Market by Region [Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Poultry Bacterial Disease Vaccine Market
The global poultry bacterial disease vaccine market has grown by leaps and bounds with the increased demand for poultry health management and the rising awareness of the importance of disease prevention. Bacterial diseases such as Salmonella, Escherichia coli, and Pasteurella are significant threats to poultry production and have led to increased demand for effective vaccines. Technological advancements in the formulation of vaccines, along with effective regulatory frameworks, have also paved the way for market growth. The United States, China, Germany, India, and Japan are key leaders in this market, all developing innovative solutions to curb bacterial diseases among poultry.
United States: In the United States, the market for poultry bacterial disease vaccines has grown with great inventions in vaccine technology. The USDA has been very crucial in promoting the licensing and utilization of vaccines for protection against a wide range of bacterial infections of poultry. Manufacturers of vaccines in the U.S. are now focusing on the advanced formulations of live attenuated vaccines and subunit vaccines for particular pathogens. This has also steered the emphasis towards vaccine development as part of the broader strategy aimed at reducing antibiotic use in poultry. These innovations help to improve the health of poultry and ensure safety in poultry products.
China: China is the world's largest producer and consumer of poultry. The poultry bacterial disease vaccine market is gaining considerable momentum. This is also because of the rapid growth of the country in the poultry production sectors, where more effective strategies in disease prevention have been increased. Chinese manufacturers increasingly adopt modern vaccine technologies, such as recombinant DNA vaccines, in combating bacterial diseases such as Salmonella and E. coli. Furthermore, the government in China has placed stricter regulations regarding poultry health, hence pushing the demand for effective vaccines. Local research and development activities also help generate affordable vaccines, which are essential for small- and medium-sized poultry farms.
Germany: Germany is one of the leading poultry bacterial disease vaccine markets in Europe, known for its strict regulation and advanced technologies of vaccines. In Germany, local manufacturers are designing multi-strain vaccines that can cover a wide variety of bacterial pathogens, including Pasteurella and E. coli. The country's strong research and development ecosystem ensures that vaccines will continue to be innovated against both national and international standards. A growing consumer preference in the German market for sustainably produced poultry is forcing market forces toward the adoption of more sustainable applications through vaccines, which minimize antibiotic use and improve poultry health in an environmentally friendlier manner.
India: The Indian poultry bacterial disease vaccine market is developing because of India's thriving poultry industry. The country is facing significant challenges related to poultry diseases. In rural and semi-urban areas, veterinary care is not easily available. In turn, the demand for affordable and effective vaccines is increasing rapidly. Indian manufacturers are targeting low-cost vaccines that are also multi-valent against bacterial diseases, such as Salmonella and Avian Cholera. The government also supports vaccination programs in poultry for healthy production, which has a direct bearing on food safety and the economics of the poultry industry.
Japan: Japan is known for its development of advanced and highly specific poultry health vaccines. The market is highly competitive, mainly due to the strict regulatory requirements and emphasis on biosecurity that Japan sets. Companies in Japan are using advanced biotechnologies for developing specific-strain vaccines against bacteria, such as Mycoplasma gallisepticum and E. coli. Consumers' increasing demand for safe, antibiotic-free poultry products is another market driver. With the emphasis of the country on technological advancements and high-quality production standards, Japan's poultry vaccine market keeps innovating in order to guarantee the healthiness of its poultry industry.
Features of the Global Poultry Bacterial Disease Vaccine Market
Market Size Estimates: Poultry bacterial disease vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Poultry bacterial disease vaccine market size by type, application, and region in terms of value ($B).
Regional Analysis: Poultry bacterial disease vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the poultry bacterial disease vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry bacterial disease vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the poultry bacterial disease vaccine market by type (live, attenuated, and killed), application (NDV, Marek's disease, IBD, infectious bronchitis, influenza, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Poultry Bacterial Disease Vaccine Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Live: Trends and Forecast (2019-2031)
4.4 Attenuated: Trends and Forecast (2019-2031)
4.5 Killed: Trends and Forecast (2019-2031)
5. Global Poultry Bacterial Disease Vaccine Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 NDV: Trends and Forecast (2019-2031)
5.4 Marek's Disease: Trends and Forecast (2019-2031)
5.5 IBD: Trends and Forecast (2019-2031)
5.6 Infectious Bronchitis: Trends and Forecast (2019-2031)
5.7 Influenza: Trends and Forecast (2019-2031)
5.8 Others: Trends and Forecast (2019-2031)
6. Regional Analysis
6.1 Overview
6.2 Global Poultry Bacterial Disease Vaccine Market by Region
7. North American Poultry Bacterial Disease Vaccine Market
7.1 Overview
7.2 North American Poultry Bacterial Disease Vaccine Market by Type
7.3 North American Poultry Bacterial Disease Vaccine Market by Application
7.4 United States Poultry Bacterial Disease Vaccine Market
